The results of these microarray experiments indicate that semi-allogeneic vaccines trigger the recruitment and activation of helper T lymphocytes and dendritic APC; in turn, these cells establish a strong Th-1 response, which leads to the activation of CTL to specifically recognize and kill their target tumor cells. This evidence concerns the gene NELFCD and neoplasm.